V. Papadimitrakopoulou

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD 1839 ( Iressa ) Suppresses cSrc and Pak 1 Pathways and Invasiveness of Human Cancer Cells

C. J. Barnes, R. Lotan, W. Hong, 2004 .

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells

J. Heymach, L. Byers, C. Pickering, 2014, Head & neck.

Response of Non–Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer

W. Hong, Y. Suh, Suyun Huang, 2005, Clinical Cancer Research.

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells

C. J. Barnes, R. Lotan, W. Hong, 2004, Clinical Cancer Research.

Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer

P. A. Futreal, Jing Wang, I. Wistuba, 2018, Nature Medicine.

Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

Yoko Takahashi, L. Milas, Mei Zhao, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells ’ Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

Yoko Takahashi, L. Milas, Mei Zhao, 2011 .

Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.

S. Lippman, A. Gillenwater, W. Hong, 1999, Archives of otolaryngology--head & neck surgery.

Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.

S. Lippman, W. Hong, J. Lee, 1998, Journal of the National Cancer Institute.

Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.

L. Mao, G. Clayman, J. Izzo, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.